CFO exercised or converted 265 IDXX derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 20, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 24, 2026
CFOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000874716-26-000125
Filed / recordedAug 24, 2026, 9:00 PM UTCAdded to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly IssuerIDEXX LABORATORIES INC /DE Reporting personAndrew Emerson Officer titleEVP, CFO and Treasurer SecurityIncentive Stock Option (right-to-buy) TableDerivative (Table II) Transaction dateAug 20, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- Not applicable
- Grant of option to buy 1,190 shares of Issuer common stock that became exercisable in one installment on February 14, 2023.
Around the same time
Derivative exercise or conversion — not an open-market buy.
A board member of Idexx Laboratories sold $1.17M of Idexx Laboratories shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.